Research Article | Open Access
Valeria Hansberg-Pastor, Ana Gabriela Piña-Medina, Aliesha González-Arenas, Ignacio Camacho-Arroyo, "C/EBPβ Isoforms Expression in the Rat Brain during the Estrous Cycle", International Journal of Endocrinology, vol. 2015, Article ID 674915, 7 pages, 2015. https://doi.org/10.1155/2015/674915
C/EBPβ Isoforms Expression in the Rat Brain during the Estrous Cycle
The CCAAT/enhancer-binding protein beta (C/EBPβ) is a transcription factor expressed in different areas of the brain that regulates the expression of several genes involved in cell differentiation and proliferation. This protein has three isoforms (LAP1, LAP2, and LIP) with different transcription activation potential. The role of female sex hormones in the expression pattern of C/EBPβ isoforms in the rat brain has not yet been described. In this study we demonstrate by western blot that the expression of the three C/EBPβ isoforms changes in different brain areas during the estrous cycle. In the cerebellum, LAP2 content diminished on diestrus and proestrus and LIP content diminished on proestrus and estrus days. In the prefrontal cortex, LIP content was higher on proestrus and estrus days. In the hippocampus, LAP isoforms presented a switch on diestrus day, since LAP1 content was the highest while that of LAP2 was the lowest. The LAP2 isoform was the most abundant one in all the three brain areas. The LAP/LIP ratio changed throughout the cycle and was tissue specific. These results suggest that C/EBPβ isoforms expression changes in a tissue-specific manner in the rat brain due to the changes in sex steroid hormone levels presented during the estrous cycle.
The CCAAT/enhancer-binding proteins (C/EBP) is a family of transcription factors that consist of six members (C/EBPα-C/EBPζ) named according to their chronological order of discovery. These proteins are solely eukaryotic and bind as dimers to specific DNA sequences to regulate gene transcription. They have a highly conserved C-terminal bZIP domain comprising a leucine-zipper dimerization domain and a basic DNA binding region. Particularly, the isotype C/EBPβ is involved in different functions such as cell proliferation and differentiation, cell survival, apoptosis, metabolism, and immune response [1, 2].
The expression of C/EBPβ is regulated by a number of factors like hormones, nutrients, cytokines, mitogens, and several transcription factors (CREB, NFκB, Sp1, and STAT-3) [2, 3]. C/EBPβ has three isoforms that are translated from a single transcript by the alternative use of different AUG initiation codons within the same open reading frame [4, 5]. C/EBPβ isoforms were first identified in the liver and therefore known as LAP1 and LAP2 (for liver activating proteins) and LIP (for liver inhibitory protein). LAP2 (34 kDa) is suggested to be a stronger transactivator than the full-length isoform LAP1 (38 kDa). The shorter isoform LIP (20 kDa) lacks the N-terminal transactivation domains and frequently acts as a dominant negative [1, 6]. However, the transactivation potential of these isoforms depends on the LAP/LIP ratio, which is important to modulate cell fate.
C/EBPβ has been associated with key functions in the central nervous system (CNS) such as learning, memory, and cognition . It is widely expressed in several brain regions, both in neurons and astrocytes [7, 8]. In the neonatal male rat brain, C/EBPβ is found in the cerebellum, cerebral cortex, hippocampus, thalamus, and brainstem. In mice neuroblastoma N2A cells, C/EBPβ participates in neurite extension and cell differentiation through the activation of PI3K signaling . In the dentate gyrus of the hippocampus, C/EBPβ is important for the proliferation of newborn cells. Mice lacking this protein have reduced newborn cell survival, decreased neuronal differentiation, and fewer cells proliferating in the subgranular zone of the dentate gyrus . Also, C/EBPβ has been associated with protection of cerebellar granular neuron death  or as part of the neuronal injury response to activate regeneration-associated genes . Despite the important role of C/EBPβ in the CNS and the different transcriptional activity of its isoforms, most studies report its expression without considering the three isoforms, usually reporting only the abundant LAP2 isoform.
Sex steroid hormones regulate a number of different processes affecting not only reproductive traits but also the CNS. Estradiol (E2) and progesterone (P4) participate in memory consolidation, cognitive functions, brain plasticity, neuronal damage protection, and brain tumors growth [13–16]. These hormones regulate these functions by modulating the expression of target genes through the interaction with its intracellular receptors [17–19]. The regulation of C/EBPβ expression by hormones has been studied in other sex hormone target organs such as endometrium and mammary gland. C/EBPβ is an essential factor during embryo implantation and decidualization in mice and primates [20–22]. Studies with knockout mice for C/EBPβ show that the animals are infertile due to failure in ovulation and luteinization . C/EBPβ is also important for E2-induced proliferation of uterine epithelial cells in nonpregnant mice  and for the normal development and function of the mammary gland . LIP isoform expression increases in the mammary gland during rat pregnancy and after parturition . There is evidence that changes in C/EBPβ isoform ratio (LAP/LIP) are important for the cellular response to ovarian P4 in the reproductive tract . C/EBPβ can also interact with estrogen receptor (ER) to induce the expression of genes involved in milk production in the mammary gland . Some recent evidence shows that C/EBPβ binds to progesterone receptor (PR) intron 2 in human uterine stromal cells, probably modulating its expression .
Notwithstanding the effects of sex hormones and C/EBPβ in different reproductive organs and the CNS, there are no studies regarding the effects of sex hormones in C/EBPβ expression in the brain. In this study we demonstrated that the expression of the three C/EBPβ isoforms in different brain areas depends on sex hormone level variations presented throughout the estrous cycle.
2. Materials and Methods
24 intact Sprague Dawley female rats (90 days of age, 250 g) certified by Harlan Laboratories, Inc. (Harlan, Mexico City, MEX) were maintained under a 12 h light-dark cycle (lights on from 6:00 am to 6:00 pm) with food and water available ad libitum. Rats, which presented at least three regular 4-day estrous cycles, were used as determined by daily vaginal smears. Rats were killed by decapitation in the morning (10:00 am) of metestrus, diestrus, proestrus, and estrus. The brains were dissected into three regions according to the Atlas of Paxinos and Watson : prefrontal cortex, hippocampus, and cerebellum. All samples were immediately processed for protein extraction. The experiments were performed according to the Official Mexican Norm (NOM-062-ZOO-1999) in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health of the USA.
2.2. Estrous Cycle Evaluation
Daily, vaginal smears were stained to determine the cycle phases of the rats. The slides with the smears were first stained with a ready-to-use hematoxylin (Biocare Medical, CA, USA) for 10 min and gently washed with tap water. Slides were dipped in a saturated lithium carbonate solution for 3 min to intensify the staining, washed with water to remove the salt, and air dried at room temperature (RT). Then, the slides were covered with alcoholic eosin (Biocare Medical, CA, USA) for 10 min, washed with 70% ethanol, and air dried at RT. The vaginal smears were observed under an optical microscope Olympus BX41 (Olympus, PA, USA).
2.3. Western Blot
Samples were homogenized in RIPA lysis buffer with protease inhibitors (1 mM EDTA, 2 μg/mL leupeptin, 2 μg/mL aprotinin, 1 mM PMSF) and proteins were obtained by centrifugation at 12500 rpm, at 4°C for 15 min and quantified using a NanoDrop 2000 Spectrophotometer (Thermo Scientific, MA, USA). 70 μg of total protein was separated by electrophoresis on a 12% SDS-PAGE at 20 mA; colored markers (Bio-Rad, CA, USA) were included for size determination. Gels were transferred to nitrocellulose membranes (Millipore, MA, USA) (35 mA) in semidry conditions at RT for 1 h. Membranes were blocked with 3% nonfat dry milk and 1% bovine serum albumin at RT for 2 h and then incubated with an antibody against the three C/EBPβ isoforms (0.6 μg/mL) (ab32358, Abcam, Cambridge, ENG) at 4°C for 48 h. Afterwards, blots were incubated with anti-rabbit secondary antibody (1 : 7500) conjugated to horseradish peroxidase (Santa Cruz Biotechnology, TX, USA) at RT for 45 min. In order to correct for differences in the amount of total protein loaded in each lane, C/EBPβ isoforms content was normalized to that of α-tubulin. Blots were stripped with glycine (0.1 M, pH 2.5, 0.5% SDS) at RT for 30 min and incubated with 0.2 μg/mL of mouse anti-α-tubulin monoclonal antibody (sc-5286, Santa Cruz Biotechnology, TX, USA) at 4°C overnight. Blots were incubated with a 1 : 3000 dilution of goat anti-mouse IgG conjugated to horseradish peroxidase (Santa Cruz Biotechnology, TX, USA) at RT for 45 min. Chemiluminescence signals were detected exposing membranes to Kodak Biomax Light Film (Sigma-Aldrich, MO, USA) using Supersignal West Femto as peroxidase substrate (Thermo Scientific, MA, USA) with a constant exposure time of 5 min for C/EBPβ and 30 seconds for α-tubulin. The antigen-antibody complex was detected as the area under a peak corresponding to a band density (the area is given in inches with a default scale of 72 pixels/inch) in a semiquantitative way using a 14.1 megapixels digital Canon camera (SD1400IS, Canon, Mexico City, MEX) and the ImageJ 1.45S software (National Institutes of Health, USA). In order to minimize interassay variations, all western blots were carried out in parallel for each brain region.
2.4. Statistical Analysis
All data were analyzed and plotted using the GraphPad Prism 5.0 software for Windows 8.1 (GraphPad Software, CA, USA). A statistical analysis between comparable groups was performed using a two-way ANOVA with a Bonferroni posttest. The LAP/LIP ratio for each brain region was analyzed using a Kruskal-Wallis test followed by a Dunn posttest. A value of was considered statistically significant as stated in the figure legends.
The three isoforms of C/EBPβ, LAP1 (38 kDa), LAP2 (34 kDa), and LIP (20 kDa) were clearly identified by western blot in the cerebellum, prefrontal cortex, and hippocampus of the rat. In all the studied brain areas the 34 kDa LAP2 isoform was the more abundant one.
In the cerebellum, the content of LAP1 showed a nonsignificant increase on estrus day. LAP2 content diminished on diestrus and proestrus days, while LIP showed a reduced content during proestrus and estrus (Figure 1). In the prefrontal cortex, LIP was the unique isoform that presented changes throughout the estrous cycle. This isoform increased its content during proestrus and estrus (Figure 2). In the hippocampus, the larger isoforms LAP1 and LAP2 showed an inverse expression on diestrus day since LAP1 content increased in this day while that of LAP2 diminished. The shorter isoform LIP did not change its content along the estrous cycle (Figure 3).
The LAP/LIP ratio changes throughout the estrous cycle in a tissue specific manner. In the cerebellum the LAP/LIP ratio increased throughout the estrous cycle from metestrus to estrus ( metestrus versus estrus), while in the prefrontal cortex the LAP/LIP ratio decreased during proestrus ( diestrus versus proestrus) and then moderately increased on estrus. In the hippocampus, the LAP/LIP ratio slightly diminished during proestrus and estrus, but no statistical significant changes were observed (Table 1).
| metestrus versus estrus, diestrus versus proestrus.|
This work demonstrates that C/EBPβ is expressed in different areas of the rat brain and changes its content throughout the estrous cycle. The three C/EBPβ isoforms LAP1, LAP2, and LIP were detected in the cerebellum, prefrontal cortex, and hippocampus. Cortés-Canteli and coworkers  previously reported the expression of C/EBPβ in all these regions in the male neonatal rat, but without studying each isoform.
Changes in sex steroid hormone levels throughout the estrous cycle influence brain function and morphology [14, 30–32]. E2 and P4 show a specific concentration pattern throughout the estrous cycle. E2 levels begin to increase during the late diestrus and show a maximum peak during the morning of proestrus. The increase in estrogen levels is followed by a rise in P4 levels during mid to late proestrus and the early estrus [33, 34]. The fluctuations in C/EBPβ isoforms content may depend on changes in E2 and P4 levels and the expression of sex hormone receptors.
In the cerebellum the decrease in LAP2 content during diestrus and proestrus could be due to the increase in E2 levels while the decrease in LIP isoform during proestrus and estrus could be related to the increase in both E2 and P4. The increase in LIP isoform content in the prefrontal cortex could also be induced by E2 and P4. The LAP isoforms change in hippocampus during diestrus could be due to the increasing levels in E2 that precede the high hormone levels observed during proestrus. Many of the effects of sex hormones depend on the actions of ER and PR that modulate target gene expression. These receptors are widely expressed in different brain areas including the cortex, hippocampus, hypothalamus, and cerebellum [35–37]. There is no evidence that C/EBPβ is directly regulated by ER and PR, but a microarray study shows that PR can induce C/EBPβ expression in breast cancer cells . Nonetheless, more studies are needed using ovariectomized animals and receptor antagonists in order to confirm the direct effect of sex hormones in C/EBPβ expression.
In addition to a transcriptional regulation, sex hormones could influence C/EBPβ isoforms translation, given that they are translated from a single mRNA . Different signal transduction pathways regulate the function of the translation initiation factors eIF2 and eIF4E, which determine the ratio of C/EBPβ isoforms . There is evidence that E2 causes polyribosomes to accumulate in the dendrites of hippocampal neurons suggesting mRNA translation regulation . In rat primary neuronal cultures of hippocampal and cortical regions, E2 increases phosphorylation of ribosomal protein S6 and eIF4E binding protein 1 (4EBP1) through the activation of ERK, and this promotes an increase in dendritic mRNA translation . These studies suggest a possible role of gonadal sex hormones in C/EBPβ isoform translation.
Sex hormones modulate the animal behavior through changing the structure and function of different brain areas. Besides mating behavior, female animals show alterations in anxiety, learning, and memory and in the response to stress depending on the estrous cycle phase [34, 42]. E2 and P4 can modulate hippocampal and cortical functions in the rat influencing learning and memory processes [43–45]. High E2 levels during proestrus enhance hippocampal memory consolidation, while in diestrus the animals show impairment in learning and memory [46, 47]. There is evidence that C/EBPβ expression in the hippocampus is associated with the consolidation of new memories [48–50]. In our study we observed a change in LAP1/2 isoform expression during diestrus in the hippocampus suggesting a possible role of these isoforms in memory consolidation.
In different cell models, the isoforms ratio is important to determine cell fate and variations in the LAP/LIP ratio can significantly activate or inhibit expression of target genes [51, 52]. The LAP/LIP ratio is therefore an important indicator of C/EBPβ transcriptional activity . In rat white adipose tissue, a caloric restriction reduced the LAP/LIP ratio, which was associated with cell differentiation . In the hepatic glucose metabolism, hyperglycemia increased the LAP/LIP ratio, which in turn promoted an increase in genes associated with gluconeogenesis . Until now there are no data available regarding the hormone regulation of the LAP/LIP ratios in the brain. In the cerebellum, the isoform ratio increases along the estrous cycle suggesting a key role of the LAP isoforms in this brain region and particularly during estrus. In contrast, the low LAP/LIP ratio during metestrus suggests an important function for the LIP isoform. In the prefrontal cortex, the decrease in the LAP/LIP ratio during proestrus suggests an important role of the LIP isoform in regulating gene expression when sex steroid hormone levels are high. Given that this isoform is usually considered as a dominant negative, its increase could downregulate different target genes. In the hippocampus the LAP/LIP ratio appears to decrease from metestrus to estrus, but given the variations in the data no significant changes were observed. However, more studies are needed to understand the actions of C/EBPβ isoforms in the brain and the role of sex hormone receptors in the regulation of such actions.
This work is the first to describe the expression of the three C/EBPβ isoforms in the brain and its changes under physiological conditions during the estrous cycle of the rat. The C/EBPβ isoforms expression in the cerebellum, prefrontal cortex, and hippocampus may be regulated by E2 and P4. The LAP and LIP isoforms expression changes throughout the estrous cycle and is tissue-specific. Our work shows important changes in the expression of C/EBPβ isoforms during the estrous cycle that might be relevant to the female reproductive adaptation.
Conflict of Interests
The authors declare that there is no conflict of interests regarding the publication of this paper.
The authors want to thank Norman Leonardo Aguilar Rosas for his help during the estrous cycle evaluation.
- J. Tsukada, Y. Yoshida, Y. Kominato, and P. E. Auron, “The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation,” Cytokine, vol. 54, no. 1, pp. 6–19, 2011.
- D. P. Ramji and P. Foka, “CCAAT/enhancer-binding proteins: structure, function and regulation,” Biochemical Journal, vol. 365, no. 3, pp. 561–575, 2002.
- M. Niehof, S. Kubicka, L. Zender, M. P. Manns, and C. Trautwein, “Autoregulation enables different pathways to control CCAAT/enhancer binding protein beta (C/EBP beta) transcription,” Journal of Molecular Biology, vol. 309, no. 4, pp. 855–868, 2001.
- P. Descombes and U. Schibler, “A liver-enriched transcriptional activator protein, LAP, and a transcriptional inhibitory protein, LIP, are translated from the same mRNA,” Cell, vol. 67, no. 3, pp. 569–579, 1991.
- C. F. Calkhoven, C. Müller, and A. Leutz, “Translational control of C/EBPα and C/EBPβ isoform expression,” Genes & Development, vol. 14, no. 15, pp. 1920–1932, 2000.
- C. A. Zahnow, “CCAAT/enhancer-binding protein β: its role in breast cancer and associations with receptor tyrosine kinases,” Expert Reviews in Molecular Medicine, vol. 11, article e12, 2009.
- D. Aguilar-Morante, M. Cortes-Canteli, M. Sanz-Sancristobal, A. Santos, and A. Perez-Castillo, “Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells,” Neuroscience, vol. 176, pp. 110–119, 2011.
- E. Sterneck and P. F. Johnson, “CCAAT/enhancer binding protein beta is a neuronal transcriptional regulator activated by nerve growth factor receptor signaling,” Journal of Neurochemistry, vol. 70, no. 6, pp. 2424–2433, 1998.
- M. Cortés-Canteli, M. Pignatelli, A. Santos, and A. Perez-Castillo, “CCAAT/enhancer-binding protein β plays a regulatory role in differentiation and apoptosis of neuroblastoma cells,” Journal of Biological Chemistry, vol. 277, no. 7, pp. 5460–5467, 2002.
- M. Cortés-Canteli, D. Aguilar-Morante, M. Sanz-SanCristobal, D. Megias, A. Santos, and A. Perez-Castillo, “Role of C/EBPβ transcription factor in adult hippocampal neurogenesis,” PLoS ONE, vol. 6, no. 10, Article ID e24842, 2011.
- E. Peña-Altamira, E. Polazzi, E. Moretto, M. Lauriola, and B. Monti, “The transcription factor CCAAT enhancer-binding protein β protects rat cerebellar granule neurons from apoptosis through its transcription-activating isoforms,” European Journal of Neuroscience, vol. 39, no. 2, pp. 176–185, 2014.
- S. Nadeau, P. Hein, K. J. L. Fernandes, A. C. Peterson, and F. D. Miller, “A transcriptional role for C/EBP β in the neuronal response to axonal injury,” Molecular and Cellular Neuroscience, vol. 29, no. 4, pp. 525–535, 2005.
- A. González-Arenas, A. G. Piña-Medina, O. González-Flores et al., “Expression pattern of Tau in the rat brain during pregnancy and the beginning of lactation,” Brain Research Bulletin, vol. 89, no. 3-4, pp. 108–114, 2012.
- B. S. McEwen, “Sex, stress and the brain: interactive actions of hormones on the developing and adult brain,” Climacteric, vol. 17, no. S2, pp. 18–25, 2014.
- J. J. Tuscher, A. M. Fortress, J. Kim, and K. M. Frick, “Regulation of object recognition and object placement by ovarian sex steroid hormones,” Behavioural Brain Research, vol. 285, pp. 140–157, 2014.
- E. Cabrera-Muñoz, A. González-Arenas, M. Saqui-Salces et al., “Regulation of progesterone receptor isoforms content in human astrocytoma cell lines,” Journal of Steroid Biochemistry and Molecular Biology, vol. 113, no. 1-2, pp. 80–84, 2009.
- J. D. Blaustein, “Steroid hormone receptors: long- and short-term integrators of the internal milieu and the external environment,” Hormone and Metabolic Research, vol. 44, no. 8, pp. 563–568, 2012.
- O. T. Hernández-Hernández, T. K. González-García, and I. Camacho-Arroyo, “Progesterone receptor and SRC-1 participate in the regulation of VEGF, EGFR and Cyclin D1 expression in human astrocytoma cell lines,” Journal of Steroid Biochemistry and Molecular Biology, vol. 132, no. 1-2, pp. 127–134, 2012.
- M. R. Foy, M. Baudry, G. K. Akopian, and R. F. Thompson, “Regulation of hippocampal synaptic plasticity by estrogen and progesterone,” Vitamins & Hormones, vol. 82, pp. 219–239, 2010.
- M. K. Bagchi, S. R. Mantena, A. Kannan, and I. C. Bagchi, “Control of uterine cell proliferation and differentiation by C/EBPβ: functional implications for establishment of early pregnancy,” Cell Cycle, vol. 5, no. 9, pp. 922–925, 2006.
- A. Kannan, A. T. Fazleabas, I. C. Bagchi, and M. K. Bagchi, “The transcription factor C/EBPβ is a marker of uterine receptivity and expressed at the implantation site in the primate,” Reproductive Sciences, vol. 17, no. 5, pp. 434–443, 2010.
- S. R. Mantena, A. Kannan, Y.-P. Cheon et al., “C/EBPβ is a critical mediator of steroid hormone-regulated cell proliferation and differentiation in the uterine epithelium and stroma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 6, pp. 1870–1875, 2006.
- H.-Y. Fan, Z. Liu, P. F. Johnson, and J. S. Richards, “CCAAT/enhancer-binding proteins (C/EBP)-α and -β are essential for ovulation, luteinization, and the expression of key target genes,” Molecular Endocrinology, vol. 25, no. 2, pp. 253–268, 2011.
- G. W. Robinson, P. F. Johnson, L. Hennighausen, and E. Sterneck, “The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland,” Genes and Development, vol. 12, no. 12, pp. 1907–1916, 1998.
- B. Raught, W. S.-L. Liao, and J. M. Rosen, “Developmentally and hormonally regulated CCAAT/enhancer-binding protein isoforms influence β-casein gene expression,” Molecular Endocrinology, vol. 9, no. 9, pp. 1223–1232, 1995.
- M. Christian, Y. Pohnke, R. Kempf, B. Gellersen, and J. A. N. J. Brosens, “Functional association of PR and CCAAT/enhancer-binding protein β isoforms: promoter-dependent cooperation between PR-B and liver-enriched inhibitory protein, or liver-enriched activatory protein and PR-A in human endometrial stromal cells,” Molecular Endocrinology, vol. 16, no. 1, pp. 141–154, 2002.
- J. Dong, C.-H. Tsai-Morris, and M. L. Dufau, “A novel estradiol/estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor,” The Journal of Biological Chemistry, vol. 281, no. 27, pp. 18825–18836, 2006.
- C. Clementi, S. K. Tripurani, M. J. Large et al., “Activin-like kinase 2 functions in peri-implantation uterine signaling in mice and humans,” PLoS Genetics, vol. 9, no. 11, Article ID e1003863, 2013.
- G. Paxinos and C. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, 6th edition, 2006.
- C. Arias, A. Zepeda, K. Hernández-Ortega, P. Leal-Galicia, C. Lojero, and I. Camacho-Arroyo, “Sex and estrous cycle-dependent differences in glial fibrillary acidic protein immunoreactivity in the adult rat hippocampus,” Hormones and Behavior, vol. 55, no. 1, pp. 257–263, 2009.
- O. Villamar-Cruz, J. Manjarrez-Marmolejo, R. Alvarado, and I. Camacho-Arroyo, “Regulation of the content of progesterone and estrogen receptors, and their cofactors SRC-1 and SMRT by the 26S proteasome in the rat brain during the estrous cycle,” Brain Research Bulletin, vol. 69, no. 3, pp. 276–281, 2006.
- A. A. Rasia-Filho, F. Dalpian, I. C. Menezes, J. Brusco, J. E. Moreira, and R. S. Cohen, “Dendritic spines of the medial amygdala: plasticity, density, shape, and subcellular modulation by sex steroids,” Histology and Histopathology, vol. 27, no. 8, pp. 985–1011, 2012.
- C. L. Chaffin and C. A. Vandevoort, “Follicle growth, ovulation, and luteal formation in primates and rodents: a comparative perspective,” Experimental Biology and Medicine, vol. 238, no. 5, pp. 539–548, 2013.
- J. Simpson and J. P. Kelly, “An investigation of whether there are sex differences in certain behavioural and neurochemical parameters in the rat,” Behavioural Brain Research, vol. 229, no. 1, pp. 289–300, 2012.
- S. L. Dean and M. M. McCarthy, “Steroids, sex and the cerebellar cortex: implications for human disease,” Cerebellum, vol. 7, no. 1, pp. 38–47, 2008.
- C. Guerra-Araiza, A. Coyoy-Salgado, and I. Camacho-Arroyo, “Sex differences in the regulation of progesterone receptor isoforms expression in the rat brain,” Brain Research Bulletin, vol. 59, no. 2, pp. 105–109, 2002.
- H. Ozawa, “Steroid hormones, their receptors and neuroendocrine system,” Journal of Nippon Medical School, vol. 72, no. 6, pp. 316–325, 2005.
- J. K. Richer, B. M. Jacobsen, N. G. Manning, M. G. Abel, D. M. Wolf, and K. B. Horwitz, “Differential gene regulation by the two progesterone receptor isoforms in human breast cancer cells,” The Journal of Biological Chemistry, vol. 277, no. 7, pp. 5209–5218, 2002.
- D. S. Peeper, “C/EBPβ: lost beyond translation,” EMBO Journal, vol. 30, no. 18, pp. 3663–3664, 2011.
- J. B. McCarthy and T. A. Milner, “Dendritic ribosomes suggest local protein synthesis during estrous synaptogenesis,” NeuroReport, vol. 14, no. 10, pp. 1357–1360, 2003.
- S. N. Sarkar, L. T. Smith, S. M. Logan, and J. W. Simpkins, “Estrogen-induced activation of extracellular signal-regulated kinase signaling triggers dendritic resident mRNA translation,” Neuroscience, vol. 170, no. 4, pp. 1080–1085, 2010.
- A. Gouveia Jr., U. D. dos Santos, F. E. Felisbino, T. L. de Afonseca, G. Antunes, and S. Morato, “Influence of the estrous cycle on the behavior of rats in the elevated T-maze,” Behavioural Processes, vol. 67, no. 2, pp. 167–171, 2004.
- L. A. Bean, L. Ianov, and T. C. Foster, “Estrogen receptors, the hippocampus, and memory,” The Neuroscientist, vol. 20, no. 5, pp. 534–545, 2014.
- A. A. Walf, M. E. Rhodes, and C. A. Frye, “Ovarian steroids enhance object recognition in naturally cycling and ovariectomized, hormone-primed rats,” Neurobiology of Learning and Memory, vol. 86, no. 1, pp. 35–46, 2006.
- A. Kato, Y. Hojo, S. Higo et al., “Female hippocampal estrogens have a significant correlation with cyclic fluctuation of hippocampal spines,” Frontiers in Neural Circuits, vol. 7, article 149, 2013.
- J. D. Cushman, M. D. Moore, R. W. Olsen, and M. S. Fanselow, “The role of the δ GABA(A) receptor in ovarian cycle-linked changes in hippocampus-dependent learning and memory,” Neurochemical Research, vol. 39, no. 6, pp. 1140–1146, 2014.
- M. I. Boulware, J. D. Heisler, and K. M. Frick, “The memory-enhancing effects of hippocampal estrogen receptor activation involve metabotropic glutamate receptor signaling,” The Journal of Neuroscience, vol. 33, no. 38, pp. 15184–15194, 2013.
- S. M. Taubenfeld, M. H. Milekic, B. Monti, and C. M. Alberini, “The consolidation of new but not reactivated memory requires hippocampal C/EBPbeta,” Nature Neuroscience, vol. 4, no. 8, pp. 813–818, 2001.
- M. Merhav, S. Kuulmann-Vander, A. Elkobi, S. Jacobson-Pick, A. Karni, and K. Rosenblum, “Behavioral interference and C/EBPβ expression in the insular-cortex reveal a prolonged time period for taste memory consolidation,” Learning and Memory, vol. 13, no. 5, pp. 571–574, 2006.
- M. H. Milekic, G. Pollonini, and C. M. Alberini, “Temporal requirement of C/EBPβ in the amygdala following reactivation but not acquisition of inhibitory avoidance,” Learning and Memory, vol. 14, no. 7, pp. 504–511, 2007.
- T. Luedde, M. Duderstadt, K. L. Streetz et al., “C/EBP β isoforms LIP and LAP modulate progression of the cell cycle in the regenerating mouse liver,” Hepatology, vol. 40, no. 2, pp. 356–365, 2004.
- Q. Wang, H. Hui, H. Yang et al., “Involvement of C/EBPβ in monocytic differentiation of acute myeloid leukemia cells induced by LW-218, a new synthesized flavonoid,” Neoplasma, vol. 61, no. 6, pp. 647–658, 2014.
- C. A. Zahnow, “CCAAT/enhancer binding proteins in normal mammary development and breast cancer,” Breast Cancer Research, vol. 4, no. 3, pp. 113–121, 2002.
- M. Zhu, G. D. Lee, L. Ding et al., “Adipogenic signaling in rat white adipose tissue: modulation by aging and calorie restriction,” Experimental Gerontology, vol. 42, no. 8, pp. 733–744, 2007.
- J. Shao, L. Qiao, R. C. Janssen, M. Pagliassotti, and J. E. Friedman, “Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio,” Diabetes, vol. 54, no. 4, pp. 976–984, 2005.
Copyright © 2015 Valeria Hansberg-Pastor et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.